2 ASX beaten down stocks could stage a reversal this month
CSL and SEEK show strong strategies, improving performance, and growth potential, making them notable picks this month.
CSL Limited (ASX: CSL)
is focused on rare conditions where treatment options are limited. Demand remains the strong across uses, with immunoglobulin as a core therapy. Its scale supports stable long-term expansion.
CSL Ltd will announce its 2026 half year result on 11 February.
The company aims to lift returns through careful use of cash. It balances funding new products and operations whereas continuing dividends and running ongoing market buybacks.
Beyond 2026, CSL expects stable sales increases, better margins and the faster profit growth. Operational leverage and efficiency gains support this outlook alongside ongoing shareholder distributions.
CSL’s leadership comes from its plasma franchise, innovation, and supply improvements. A broad pipeline, balanced markets, and structural changes position the business well for sustained future performance.
SEEK Limited (ASX: SEK)
will record a large write-down linked to its holding in Zhaopin as part of its FY26 half-year process. The change is due to softer market conditions, reduced earnings expectations, and shifts in ownership and management, which lowered the asset’s value.
Despite this, FY25 operations remained healthy. After platform consolidation, the business delivered strong results, higher shareholder payouts, lower debt and stronger balance sheet resilience.
Market performance improved across regions with higher placement share and double digit yield uplift driven by pricing and product changes. Costs increased at a slower pace than income, supporting efficiency.
SEEK’s direction centres on strengthening leadership, lifting yields and ensuring revenue grows faster than expenses.
(Source: Company Report)
Get Your Free Report on Top 5 ASX Stocks on WhatsApp
Instant Access. No Credit Card Required.
Receive on WhatsApp
Checkout Our Recommendation for free - 7 days free trial
Start Free TrialASX Stock Research & Recommendations — 7‑day free trial
Independent, analyst‑driven insights.
- Stock of the week report
- Daily Analysis Report
- No credit card required
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Article
Disclaimer
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
